CPHQ Exam Questions Tutorials

Active surveillance in healthcare is a proactive approach to identifying and monitoring health-related events or diseases123. It involves the continuous, systematic collection, analysis, and interpretation of health-related data needed for the planning, implementation, and evaluation of public health practice1.

Option B, “Identifying disease outbreaks through public health contact tracing,” is an example of active surveillance. Contact tracing is a key strategy for preventing the further spread of infectious diseases. It involves identifying people who have an infectious disease (cases) and their contacts (people who may have been exposed) and working with them to interrupt disease transmission12.

Option A, “analyzing laboratory data for disease testing utilization,” could be part of both active and passive surveillance, depending on the context. However, it does not necessarily involve the proactive steps typically associated with active surveillance13.

Option C, “analyzing infectious diseases based on hospital discharge final coding,” is more related to passive surveillance, which involves the collection of data as they become available, or the data that are passively received by health care providers or health information systems13.

Option D, “reporting of infectious diseases data quarterly to local health departments,” is also more related to passive surveillance, as it involves regular reporting of health data from various sources13.

Clinical pathways (CPWs) are a common component in the quest to improve the quality of health1. They are used to reduce variation, improve quality of care, and maximize the outcomes for specific groups of patients1. The development of a clinical pathway involves a structured multidisciplinary plan of care1. This process includes translating guidelines or evidence into local structures1.

Therefore, during the development of a clinical pathway, a quality professional should consult peer-reviewed evidence. This is because the evidence forms the basis of the guidelines that are translated into the local structures during the development of the clinical pathway1. This ensures that the care provided is based on the most current and best practice, leading to improved patient outcomes2.

It’s important to note that while evaluating peer review committee findings, implementing best practice alerts, and gathering patient outcome data can be part of the overall quality improvement process, they are not specifically part of the development of a clinical pathway34. These activities may occur before or after the development of the clinical pathway but are not integral to the development process itself34.

A confidential reporting system is a voluntary system that allows healthcare professionals to report patient safety incidents or near misses without fear of legal or professional repercussions12.

The purpose of a confidential reporting system is to enhance the data available to assess and resolve patient safety and quality issues, and to encourage the reporting and analysis of medical errors12.

A confidential reporting system is different from an anonymous reporting system, where the reporter’s identity is unknown, or a nonconfidential reporting system, where the reporter’s identity is disclosed3.

In a confidential reporting system, the reporter’s identity is hidden from authorities, such as legal authorities, regulatory groups, or the public12. However, the reporter’s identity may be known to the entity that operates the reporting system, such as a patient safety organization (PSO) or a healthcare organization12.

The reporter’s identity is protected by federal privilege and confidentiality protections under the Patient Safety and Quality Improvement Act of 2005 (PSQIA)12. This means that the reporter’s identity and the information reported cannot be used for legal or regulatory purposes, or disclosed to anyone without the reporter’s consent12.

Therefore, the correct answer is A. hidden from authorities, because in a confidential reporting system, the reporter’s identity is not revealed to anyone outside the reporting system, unless the reporter agrees to do so. References: 1: Understanding Patient Safety Confidentiality 2: Confidential Physician Feedback Reports: Designing for Optimal Impact on Performance 3: Quality - Safety & Confidentiality - General - AIHC

The Pareto chart is the most useful tool for the Performance Improvement Committee to determine educational targets based on aggregated occurrence report data. The Pareto chart helps to prioritize areas for improvement by showing the frequency or impact of different causes of problems, following the 80/20 rule (where 80% of problems often stem from 20% of causes). By identifying the most significant issues, the committee can focus its limited resources on the areas that will have the greatest impact on improving staff performance and patient outcomes.

Force field analysis (A): This tool is used for decision-making by analyzing forces for and against a change, but it is less suited for prioritizing based on frequency data.

Control chart (B): Used to monitor process stability over time, not for prioritization.

Scattergram (D): Used to identify correlations between variables, not for prioritizing educational targets.

References

NAHQ Body of Knowledge: Quality Improvement Tools and Techniques

NAHQ CPHQ Exam Preparation Materials: Using Pareto Charts in Performance Improvement

=========